MedTruth Editors · September 13, 2023
Plaintiffs allege that they developed bladder, breast, prostate or other cancers because of long-term usage of Zantac or its generic, over-the-counter equivalent ranitidine.
Legal DevelopmentsMedTruth Editors · July 28, 2023
The plaintiffs allege that Zantac caused them to develop cancer of nine different types, including colorectal, breast, and bladder cancer.
Legal DevelopmentsMedTruth Editors · July 3, 2023
An individual who claimed to have developed bladder cancer due to the heartburn medication Zantac has reached a settlement with the manufacturer of the drug.
Legal DevelopmentsMedTruth Editors · September 13, 2023
Plaintiffs allege that they developed bladder, breast, prostate or other cancers because of long-term usage of Zantac or its generic, over-the-counter equivalent ranitidine.
Legal DevelopmentsMedTruth Editors · July 28, 2023
The plaintiffs allege that Zantac caused them to develop cancer of nine different types, including colorectal, breast, and bladder cancer.
Legal DevelopmentsMedTruth Editors · July 3, 2023
An individual who claimed to have developed bladder cancer due to the heartburn medication Zantac has reached a settlement with the manufacturer of the drug.
Legal Developments
Zantac and its generic forms have been linked to cancers by numerous patients in ongoing lawsuits.
MedTruth Editors · April 12, 2023
The ruling will allow a lawsuit by a California resident, who claims he developed bladder cancer because of Zantac, to move forward in a state court.
Legal DevelopmentsMedTruth Editors · March 3, 2023
The outcome of the case will be heavily influenced by which expert testimony Judge Grillo allows.
Legal DevelopmentsMedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsMedTruth Editors · September 13, 2023
Plaintiffs allege that they developed bladder, breast, prostate or other cancers because of long-term usage of Zantac or its generic, over-the-counter equivalent ranitidine.
Legal DevelopmentsMedTruth Editors · July 28, 2023
The plaintiffs allege that Zantac caused them to develop cancer of nine different types, including colorectal, breast, and bladder cancer.
Legal DevelopmentsMedTruth Editors · July 3, 2023
An individual who claimed to have developed bladder cancer due to the heartburn medication Zantac has reached a settlement with the manufacturer of the drug.
Legal DevelopmentsMedTruth Editors · June 14, 2023
Over 50,000 Zantac lawsuits have been dismissed, with over 100,000 still pending. The cases claim the drug’s active ingredient, ranitidine, causes cancer.
Legal DevelopmentsMedTruth Editors · May 26, 2023
The court ruled that the plaintiff lacked the evidence necessary to convince the court that ranitidine, the active ingredient in Zantac, showed any causation to cancer.
Legal DevelopmentsMedTruth Editors · April 12, 2023
The ruling will allow a lawsuit by a California resident, who claims he developed bladder cancer because of Zantac, to move forward in a state court.
Legal DevelopmentsMedTruth Editors · March 8, 2023
The judge overseeing this Zantac case is still deliberating over what expert testimony to admit.
Legal DevelopmentsMedTruth Editors · March 3, 2023
The outcome of the case will be heavily influenced by which expert testimony Judge Grillo allows.
Legal DevelopmentsMedTruth Editors · February 8, 2023
Generic makers of the heartburn drug Zantac are asking the judge to issue a final judgment that would toss out claims against them in the MDL.
Legal DevelopmentsMedTruth Editors · January 4, 2023
Zantac manufacturers have been cleared from liability in causing plaintiffs’ various types of cancers.
Legal DevelopmentsMedTruth Editors · November 30, 2022
The Plumbers & Pipefitters Local Union alleged that Zantac contained a carcinogenic substance, and as a result, the heartburn drug manufacturers should be forced to pay monetary damages.
Legal DevelopmentsMedTruth Editors · October 18, 2022
Plaintiffs seek permission to file a report that includes data from a study that suggests ranitidine is associated with four different types of cancer.
Legal DevelopmentsMedTruth Editors · October 14, 2022
Depending on what type of cancer plaintiffs have, they will either be tried at the state or federal level.
Legal DevelopmentsMedTruth Editors · September 27, 2022
These special hearings will determine which expert witnesses will be allowed to testify in the Zantac trials.
Legal DevelopmentsMedTruth Editors · August 31, 2022
Joseph Bayer agreed to drop his lawsuit, which was scheduled to be held in an Illinois state court, after reaching a settlement of more than $500,000 with generic makers of Zantac.
Legal DevelopmentsMedTruth Editors · July 6, 2022
The first four Zantac trials in California have been set for 2023. Zantac users claim that they were unknowingly exposed to unsafe levels of NDMA.
Legal DevelopmentsMedTruth Editors · June 1, 2022
Beal's trial is the largest award in the MDL in which a jury has ordered the company to pay a single plaintiff.
Legal DevelopmentsMedTruth Editors · April 15, 2022
The recall affects 13 lots of the muscle pain and spasm drug Orphenadrine Citrate.
NewsMedTruth Editors · April 6, 2022
Pfizer detected a potentially carcinogenic compound in the blood pressure lowering drug Accuretic.
NewsMedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsMedTruth Editors · February 15, 2022
GlaxoSmithKline will not be able to subpoena documents from plaintiffs in the Zantac multidistrict litigation.
Legal DevelopmentsMedTruth Editors · December 13, 2021
Old Spice men’s cologne and Secret deodorant aerosol cans were found to have detectable levels of benzene, a known human carcinogen that may cause cancer.
NewsMedTruth Editors · October 21, 2021
Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.
Legal DevelopmentsMedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsMedTruth Editors · August 17, 2021
Judge Rosenberg determined that the lawsuits against the generic manufacturer are preempted since the law does not allow the generics to be labeled differently.
Legal DevelopmentsNicole Knight · October 15, 2020
The FDA has announced two additional voluntary recalls of extended-release metformin.
FDA RegulationMedTruth Editors · September 8, 2020
The FDA announced new guidance on Sept. 1 for drugmakers, citing “serious concerns” about common medications.
FDA RegulationMedTruth Editors · September 1, 2020
The U.S. Department of Justice is investigating whether drugmakers violated the False Claims Act by possibly failing to disclose the presence of NDMA in their Zantac and generic ranitidine heartburn products.
NewsJames Parker · June 12, 2020
Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.
Legal DevelopmentsMedTruth Editors · May 29, 2020
Metformin was voluntarily recalled after N-Nitrosodimethylamine (NDMA) was discovered in a single lot of Apotex’s product.
FDA RegulationJoanna Shawn Brigid O'Leary · May 28, 2020
The active ingredient in Pepcid heartburn medication, famotidine, may be an effective treatment for the coronavirus.
Research + FindingsAshley Lombardo · April 1, 2020
On April 1, the U.S. Food and Drug Administration requested immediate removal of Zantac products from the U.S. market, including all prescription and over-the-counter medications containing ranitidine.
NewsJames Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsBenjamin Duong · February 11, 2020
Canada is facing shortages of heartburn medications after a Zantac recall led to an increase in demand for alternatives.
NewsCarah Wertheimer · January 28, 2020
Congresswoman Rosa DeLauro has fought for equal pay for women, the creation of middle-class jobs, and wellbeing for veterans, along with public health and patient safety issues.
Health FeaturesJames Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsJames Parker · January 8, 2020
An investigation will determine whether the diabetes drug metformin contains dangerously elevated levels of the carcinogen NDMA, as part of a larger movement to examine a wide spectrum of medications for unsafe levels of contamination.
FDA RegulationBenjamin Duong · January 14, 2020
Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.
NewsJames Parker · January 13, 2020
Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.
FDA RegulationJune 14, 2023
May 26, 2023
April 12, 2023
March 8, 2023
March 3, 2023
February 8, 2023
January 4, 2023
November 30, 2022
October 18, 2022
October 14, 2022
September 27, 2022
August 31, 2022
July 6, 2022
June 1, 2022
April 15, 2022
April 6, 2022
March 2, 2022
February 15, 2022
December 13, 2021
October 21, 2021
September 29, 2021
August 17, 2021
October 15, 2020
September 8, 2020
September 1, 2020
June 12, 2020
May 28, 2020
April 1, 2020
March 4, 2020
February 11, 2020
January 28, 2020
January 15, 2020
January 8, 2020
January 14, 2020
January 13, 2020